ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Cytokinetics Inc. (CYTK)

Nasdaq · Common stock · Pharmaceutical Preparations

$63.16-0.79 (-1.23%)

As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow CYTK in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on CYTK and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free CYTK chart →

CYTK at a glance

Key statistics

$8.89B

Market capitalization

Previous close
$63.95
Open
$64.16
Day range
$63.03 – $64.78
Volume
449.5K
Average volume (30 sessions)
2.09M
Shares outstanding
124.43M
Earnings per share
$(6.43)
Price / sales
131.4
Beta (1 year, vs SPY)
0.81

Where the price sits in its year

52-week range

26% of the range

Below the 52-week high
-28.5%
Above the 52-week low
+16.3%

Completed sessions through Oct 20, 2026

Technical snapshot

Below its 50-day and 200-day averages

20-day average
$63.77+0.3%
50-day average
$69.71-8.3%
200-day average
$70.14-8.8%
RSI (14)44.2

Between the conventional 30 and 70 bands.

+3.8%

1 week

-5.3%

1 month

-22.2%

3 months

+0.6%

Year to date

+9.4%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with CYTK

Every plan

CYTK on Pro Charting

Every intraday interval in real time, the drawing kit and the full set of technical studies on CYTK.

See the plans →

Every plan

Screen names like CYTK

The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.

See the plans →

Analysis Tools Only

Set a price line on CYTK

Put CYTK on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.

See the plans →

Stock Alerts + Tools

Open alerts on CYTK

See whether there is an open premium alert on CYTK, with its entry, stop and exit, each one reviewed by an analyst before it is sent.

See the plans →

From the public news wire

CYTK headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →

  • Harrington Robert Arthur

    +195

    Director · Grant or award

    $12.46K · Oct 16, 2026

  • Malik Fady Ibraham

    −3.5K

    EVP Research & Development · Option exercise

    · Oct 20, 2026

  • WIERENGA WENDELL

    +97

    Director · Grant or award

    $6.20K · Oct 16, 2026

  • Malik Fady Ibraham

    −3.5K

    EVP Research & Development · Open-market sale

    $224.04K · Oct 20, 2026

  • Kaye Edward M. MD

    +195

    Director · Grant or award

    $12.46K · Oct 16, 2026

  • Malik Fady Ibraham

    +3.5K

    EVP Research & Development · Option exercise

    $27.30K · Oct 20, 2026

  • Daly James M

    +195

    Director · Grant or award

    $12.46K · Oct 16, 2026

  • Wysenski Nancy

    +97

    Director · Grant or award

    $6.20K · Oct 16, 2026

About Cytokinetics Inc.

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
South San Francisco, CA
Employees
673
Listed since
Apr 29, 2004
Website
cytokinetics.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.